15th Jun 2015 08:39
LONDON (Alliance News) - Circassia Pharmaceuticals PLC said Monday that its GBP139 million cash offer for Sweden-listed Aerocrine AB has been declared unconditional, and it has extended the acceptance period for the offer to June 26.
Some 647.1 million shares have been tendered in the offer, equivalent to around 92.6% of Aerocrine's issued share capital. The offer period ended last Thursday, but Circassia has extended the acceptance period to provide the remaining shareholders in Aerocrine time to consider and accept the offer.
Shares in Circassia are trading up 1.4% at 285.00 pence Monday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
CIR.L